Vestech, working with Cryptych P/L, Spinal Developments P/L and Sabre P/L has developed a sterile, single-use driver for the Precision screw. The driver, which securely grips the screw and releases it once inserted, without moving parts, is now available in a sterile single use pack allowing surgeons and hospitals greater flexibility in utilizing the Precision […]
Vestech helps achieve CE Mark, TGA approval and FDA clearance for Cryptych’s innovative spinal implant.
Dr Carlotta Duncan, the Director for Scientific Advancement at the Buck Institute for Research on Ageing, gave Vestech’s CEO, Dr Greg Roger a tour of the Institute’s facility in Novato California.
The Australian Institute of Physics held the day long “Physics of the Mind” symposium at CSIRO’s East Lindfield site this month. A wide variety of speakers, from the driving force behind IBM’s Jeopardy winning Watson computer to a Phd Physicist turned Buddhist guru, spoke to the diversity of issues in understanding the mind.
Vestech recently visited the Archibald Prize exhibition during a Corporate Sponsors evening, taking up the opportunity to view the artworks without the usual hustle and bustle of regular gallery hours. Good corporate citizenship is a key guiding principle of Vestech. Additionally, exposure to the creative arts stimulates the mind and assists in the inventive process. Plus […]
The time is now for Australia to take definitive steps to promote a thriving Medical Device sector which employs people, creates wealth and improves Australia’s future in a competitive world. CSL’s decision to locate a new plant in Switzerland speaks to the need for the AIM Tax Incentive, which has been clearly shown.
Vestech headlined the Medical Devices Seminar, sponsored by ICN WA, on August 12th, 2014. Attendees from across industry heard from Vestech’s CEO, Dr Greg Roger, as well as Dr Cheryl McRae of the TGA, James Brennan of Design and Industry and Dr Stewart Washer of Cynata Therapuetics.
Removing bureaucratic hurdles, through the JOBS Act in the US, has been shown to directly stimulate commercialisation of innovation.
estech’s CEO, Dr Greg Roger, will be chairing a seminar in Perth August 12 for ICN. This seminar, covering Regulatory Issues and Commercialisation Essentials is a development from the two seminars held in Sydney and Melbourne in MAy and June this year as part of the Federal Government’s Advocate Program.
The CONVERGE Summit for Healthcare Innovation, held in Philadelphia July 15th to 16th has been opened to the world by webcasting. Increasingly the teachings of the world’s best and brightest is open to innovators in every corner of the world.